AnaptysBio Inc (NASDAQ:ANAB)
| 17.97 Delayed Data As of Sep 29 |  -0.03 / -0.17%Today’s Change | 16.51 Today|||52-Week Range 32.44 | -42.01% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 17.6M | 16.7M | 10.0M | 5.0M | |
| Depreciation And Amortization | 274.0K | 233.0K | 183.0K | 315.0K | ||
| Operating Expenses | Gross Income | -- | 16.5M | -- | -- | |
| General Expenses | 20.6M | 19.5M | 38.6M | 71.5M | ||
| Research And Development | 17.3M | 15.4M | 29.4M | 56.3M | ||
| Total Operating Expenses | 20.9M | 19.7M | 38.8M | 71.8M | ||
| Non-Operating Expenses | Operating Income | -3.3M | -3.0M | -28.8M | -66.8M | |
| Extraordinary Charge | -1.3M | -756.0K | -1.4M | 0.00 | ||
| Interest Expense On Debt | 460.0K | 458.0K | 1.8M | 1.7M | ||
| Other Expenses | -207.0K | -20.0K | 229.0K | -159.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -5.3M | -4.3M | -30.1M | -61.9M | |
| Income Taxes | -139.0K | 0.00 | 0.00 | -292.0K | ||
| Net Income | -5.4M | -4.3M | -30.1M | -61.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 19.9M | 19.9M | 19.8M | 24.7M | |
| Shares To Calculate EPS Diluted | 19.9M | 19.9M | 19.8M | 24.7M | ||
| Earnings Per Share | EPS | -$0.27 | -$0.21 | -$1.52 | -$2.50 | |
| EPS Diluted | -$0.27 | -$0.21 | -$1.52 | -$2.50 | ||
